Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG

R.B. Walter; M. Othus; B. Lowenberg; G.J. Ossenkoppele; S.H. Petersdorf; T. Pabst; M.C. Vekemans; F.R. Appelbaum; H.P. Erba; E.H. Estey

doi:10.3324/haematol.2015.130013

Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG

R.B. Walter, M. Othus, B. Lowenberg, G.J. Ossenkoppele, S.H. Petersdorf, T. Pabst, M.C. Vekemans, F.R. Appelbaum, H.P. Erba, E.H. Estey

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	E409-E411
Journal	Haematologica
Volume	100
Issue number	10
DOIs	https://doi.org/10.3324/haematol.2015.130013
Publication status	Published - 2015

Access to Document

10.3324/haematol.2015.130013

Cite this

Walter, R. B., Othus, M., Lowenberg, B., Ossenkoppele, G. J., Petersdorf, S. H., Pabst, T., ... Estey, E. H. (2015). Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG. Haematologica, 100(10), E409-E411. https://doi.org/10.3324/haematol.2015.130013

Walter, R.B. ; Othus, M. ; Lowenberg, B. ; Ossenkoppele, G.J. ; Petersdorf, S.H. ; Pabst, T. ; Vekemans, M.C. ; Appelbaum, F.R. ; Erba, H.P. ; Estey, E.H. / Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG. In: Haematologica. 2015 ; Vol. 100, No. 10. pp. E409-E411.

@article{0ccb8d8799fd46e7a8ae7ecd00c765fb,

title = "Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG",

author = "R.B. Walter and M. Othus and B. Lowenberg and G.J. Ossenkoppele and S.H. Petersdorf and T. Pabst and M.C. Vekemans and F.R. Appelbaum and H.P. Erba and E.H. Estey",

year = "2015",

doi = "10.3324/haematol.2015.130013",

language = "Undefined/Unknown",

volume = "100",

pages = "E409--E411",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "10",

}

Walter, RB, Othus, M, Lowenberg, B, Ossenkoppele, GJ, Petersdorf, SH, Pabst, T, Vekemans, MC, Appelbaum, FR, Erba, HP & Estey, EH 2015, 'Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG', Haematologica, vol. 100, no. 10, pp. E409-E411. https://doi.org/10.3324/haematol.2015.130013

Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG. / Walter, R.B.; Othus, M.; Lowenberg, B.; Ossenkoppele, G.J.; Petersdorf, S.H.; Pabst, T.; Vekemans, M.C.; Appelbaum, F.R.; Erba, H.P.; Estey, E.H.

In: Haematologica, Vol. 100, No. 10, 2015, p. E409-E411.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG

AU - Walter, R.B.

AU - Othus, M.

AU - Lowenberg, B.

AU - Ossenkoppele, G.J.

AU - Petersdorf, S.H.

AU - Pabst, T.

AU - Vekemans, M.C.

AU - Appelbaum, F.R.

AU - Erba, H.P.

AU - Estey, E.H.

PY - 2015

Y1 - 2015

U2 - 10.3324/haematol.2015.130013

DO - 10.3324/haematol.2015.130013

M3 - Article

C2 - 26160876

VL - 100

SP - E409-E411

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 10

ER -